Repositorio Dspace

Non-vitamin K Antagonist Oral Anticoagulants and Drug-Food Interactions: Implications for Clinical Practice and Potential Role of Probiotics and Prebiotics

Mostrar el registro sencillo del ítem

dc.contributor.author Sánchez-Fuentes, Ana
dc.contributor.author Rivera-Caravaca, José-Miguel
dc.contributor.author López-Gálvez, Raquel
dc.contributor.author Marín, Francisco
dc.contributor.author Marín, Francisco
dc.contributor.author Roldán-Schilling, Vanessa
dc.contributor.author Roldán-Schilling, Vanessa
dc.date.accessioned 2025-11-21T08:43:52Z
dc.date.available 2025-11-21T08:43:52Z
dc.date.issued 2022-01-17
dc.identifier.citation Sánchez-Fuentes A, Rivera-Caravaca JM, López-Gálvez R, Marín F, Roldán V. Non-vitamin K Antagonist Oral Anticoagulants and Drug-Food Interactions: Implications for Clinical Practice and Potential Role of Probiotics and Prebiotics. Front Cardiovasc Med. 17 de enero de 2022;8:787235.
dc.identifier.issn 2297-055X
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/21910
dc.description.abstract Non-vitamin K antagonist oral anticoagulants (NOACs) are a therapeutic option to prevent stroke in patients with atrial fibrillation (AF). In fact, NOACs have become the recommended choice by international clinical practice guidelines over vitamin K antagonists (VKA), because of their efficacy and safety profile, especially in newly initiated patients. The more predictable pharmacokinetic and pharmacodynamic profile of this family of drugs allows preventing anticoagulation drug monitoring. Furthermore, NOACs have significantly fewer drug and food interactions in comparison with VKAs. Despite this, there are no studies that compare the effects on the quality of anticoagulation of NOACs with the intake of potential interactions drugs of P-glycoprotein and cytochrome P450 (CYP). This review brings an overview of NOACs pharmacokinetics profile and their potential drug-food interactions. We also briefly discuss the potential role of prebiotics and probiotics in patients under therapy with NOACs.
dc.language.iso eng
dc.publisher FRONTIERS MEDIA SA
dc.rights Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional *
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/es/  *
dc.title Non-vitamin K Antagonist Oral Anticoagulants and Drug-Food Interactions: Implications for Clinical Practice and Potential Role of Probiotics and Prebiotics
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 35111826
dc.relation.publisherversion https://www.frontiersin.org/articles/10.3389/fcvm.2021.787235/full
dc.identifier.doi 10.3389/fcvm.2021.787235
dc.journal.title Frontiers in Cardiovascular Medicine


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta